PBSV insider transaction filings
Pharma-Bio Serv, Inc. — 16 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-22. Screen PBSV transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| SPINDEL HOWARD — Director | 1 | — | — | 1 |
Recent Form 4 filings — Pharma-Bio Serv, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-22 | 4 | SPINDEL HOWARD — Director | Other (J): 42,504 @ $0 | EDGAR |
| 2026-01-14 | 4 | MICHEL KIRK WHEELER — Chairman, Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | SPINDEL HOWARD — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | WIESEN IRVING L — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Perlysky Dov — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | MICHEL KIRK WHEELER — Chairman, Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | SPINDEL HOWARD — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | WIESEN IRVING L — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | Perlysky Dov — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | WIESEN IRVING L — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | MICHEL KIRK WHEELER — Chairman, Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | SPINDEL HOWARD — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Perlysky Dov — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | MICHEL KIRK WHEELER — Chairman, Director | Option exercise (M): 20,000 @ $0.76 · Tax withholding (F): 14,340 @ $1.06 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | SPINDEL HOWARD — Director | Option exercise (M): 20,000 @ $1 · Tax withholding (F): 18,868 @ $1.06 · Gift (G): 1,132 @ $0 · Gift (G): 1,132 @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | LASANTA PEDRO J — Chief Financial Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Pharma-Bio Serv, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PBSV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →